Vulvar Cancer: A Hidden Disease Sep 5, 2008
Vulvar cancer is the fourth most common cancer of the female genital tract. In 2008, roughly 3,460 cases of vulvar cancer will be diagnosed in the United States and about 870 will die of this cancer, according to the American Cancer Society ... There are several different types of vulvar cancer. (Newsmax)
Mothers less likely to pursue HPV vaccination for youngest daughters May 5, 2008
In June 2006, the U.S. Food and Drug Administration approved a vaccine against four types of HPV, 6, 11, 16 and 18, based on data from clinical trials indicating that the vaccine was highly effective in preventing persistent infection with these strains and subsequent cervical cancer precursor lesions, vaginal and vulvar cancer precursor lesions and genital warts. The FDA approved the HPV vaccine for use in U.S. women aged 9 to 26 years. (EurekAlert!)
Topical Cream Treats Precancerous Lesions of Vulva Apr 4, 2008
Seters stressed that the cream was tested only as a treatment for the precancerous disease -- not vulvar cancer itself. "And we don't believe it'll work in vulvar cancer itself, because the invasive cancer itself is not as much related to the HPV virus," she said ... Vulvar cancer is a relatively rare disease that typically develops slowly over many years, often preceded by precancerous changes occurring in a woman's outer genitalia, within the tissues surrounding the opening of the vagina. (MEDLINEplus)
Thursday's Stocks to Watch Jun 21, 2007
The application includes data on protection against vaginal and vulvar cancer caused by HPV types 16 and 18, and data on immune memory, the Whitehouse Station, N.J.-based pharmaceutical company said. Merck said it expects the FDA to act on the application in the first quarter of 2008. (Fox News)
Cervical cancer vaccine protects for at least three years May 10, 2007
BOSTON, Massachusetts (Reuters) -- Merck's Gardasil vaccine protects against cervical cancer caused by a sexually transmitted wart virus for at least three years and also prevents lesions that can grow into vaginal and vulvar cancer, according to two studies published on Wednesday. And a third study concluded the virus may cause a significant number of throat cancers in men and women, probably due to oral sex. (CNN -- Health)
Merck's HPV shot 'works for three years' May 10, 2007
Merck's Gardasil vaccine protects against cervical cancer caused by a sexually transmitted wart virus for at least three years and also prevents lesions that can grow into vaginal and vulvar cancer, two studies show. And a third study concluded the virus may cause a significant number of throat cancers in men and women, probably due to oral sex. (Sydney Morning Herald -- World)
List of Cancers Jan 27, 2007
There are many common cancers and many more not-so-common ones. Cancer is actually a large and diverse group of diseases. (Suite101.com)
The vaccine route to cancer prevention Nov 19, 2006
They also cause vaginal and vulvar cancer, penile cancer, anal cancer, head and neck cancer, and larynx cancer, Prof Stanley notes. When women go for Pap smear tests, the small sample of cells taken from their cervix is examined for CINs. (Malaysia Star)
Vaccine 'cuts cancer deaths by 76%' Sep 7, 2006
Males develop penile and anal cancer from the same strains as those found in cervical and vulvar cancer. Also, many head and neck cancers are also related to the same strains and some additional strains of HPV. Some cancers like tonsil cancer is almost 100% related to HPV. Other cancers like lip cancer is also primarily due to HPV. Some times HPV and Epstein Bar act together to cause cancer like nasal cavity cancer. (Yahoo News -- Cancer)
Cervical cancer vaccine approved in Canada Jul 21, 2006
Last Updated Tue, 18 Jul 2006 17:47:02 EDT. Health Canada has approved a vaccine that protects against the human papilloma virus, or HPV, which is responsible for most cases of cervical cancer, the vaccine's manufacturer announced Tuesday. (CBC - Newfoundland & Labrador)
CDC panel recommends HPV vaccine for girls, women Jun 30, 2006
Studies of the vaccine also showed it offered protection against cases of vaginal and vulvar cancer linked to HPV infection. The Food and Drug Administration approved the vaccine for use in girls and women ages 9 to 26 earlier this month. (MarketWatch)
FDA Approves Cervical Cancer Vaccine Jun 9, 2006
Learn about the most common cancers, who gets them and how they are treated. Explore health issues including AIDS, cancer and antibiotics. (CBS News)
Merck Cervical Cancer Vaccine Wins Approval Jun 9, 2006
The vaccine also is believed to offer protection against some cases of vaginal and vulvar cancer, as well. (MORE TO FOLLOW) Dow Jones Newswires. (SmartMoney)
